S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
Log in
NASDAQ:MRUS

Merus News Headlines

$22.74
+1.21 (+5.62 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.40
Now: $22.74
$22.94
50-Day Range
$20.50
MA: $24.66
$29.11
52-Week Range
$10.18
Now: $22.74
$31.27
Volume109,807 shs
Average Volume198,277 shs
Market Capitalization$718.65 million
P/E RatioN/A
Dividend YieldN/A
Beta0.83

Headlines

Merus (NASDAQ MRUS) News Headlines Today

Source:
SourceHeadline
Merus (NASDAQ:MRUS) Stock Price Up 5.6%Merus (NASDAQ:MRUS) Stock Price Up 5.6%
americanbankingnews.com - March 5 at 7:54 PM
Merus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - NasdaqMerus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Nasdaq
nasdaq.com - March 5 at 1:28 PM
Merus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Yahoo FinanceMerus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Yahoo Finance
finance.yahoo.com - March 4 at 5:25 PM
Merus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseMerus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - March 4 at 5:25 PM
 Analysts Expect Merus (NASDAQ:MRUS) Will Announce Earnings of -$0.62 Per Share Analysts Expect Merus (NASDAQ:MRUS) Will Announce Earnings of -$0.62 Per Share
americanbankingnews.com - March 1 at 9:01 AM
Zacks: Brokerages Expect Merus (NASDAQ:MRUS) Will Announce Earnings of -$0.62 Per ShareZacks: Brokerages Expect Merus (NASDAQ:MRUS) Will Announce Earnings of -$0.62 Per Share
americanbankingnews.com - March 1 at 8:29 AM
Merus (NASDAQ:MRUS) Trading Up 9.8%Merus (NASDAQ:MRUS) Trading Up 9.8%
americanbankingnews.com - February 26 at 6:46 PM
Short Interest in Merus (NASDAQ:MRUS) Rises By 67.8%Short Interest in Merus (NASDAQ:MRUS) Rises By 67.8%
americanbankingnews.com - February 14 at 5:58 AM
InvestorNewsBreaks – Merus NV (NASDAQ: MRUS) Secures $138M in Underwritten Public Offering - StreetInsider.comInvestorNewsBreaks – Merus NV (NASDAQ: MRUS) Secures $138M in Underwritten Public Offering - StreetInsider.com
streetinsider.com - February 4 at 9:20 AM
Merus to Participate in Upcoming Investor Conferences - Yahoo Finance UKMerus to Participate in Upcoming Investor Conferences - Yahoo Finance UK
uk.finance.yahoo.com - February 1 at 2:42 PM
Merus to Participate in Upcoming Investor ConferencesMerus to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 1 at 9:42 AM
Merus Announces Pricing of Public Offering of Common Shares - Yahoo FinanceMerus Announces Pricing of Public Offering of Common Shares - Yahoo Finance
finance.yahoo.com - January 22 at 1:50 PM
Merus prices $120M public offering - Seeking AlphaMerus prices $120M public offering - Seeking Alpha
seekingalpha.com - January 21 at 12:14 PM
Merus Announces Pricing of Public Offering of Common Shares - GlobeNewswireMerus Announces Pricing of Public Offering of Common Shares - GlobeNewswire
globenewswire.com - January 21 at 12:14 PM
Form S-3MEF Merus NV - StreetInsider.comForm S-3MEF Merus NV - StreetInsider.com
streetinsider.com - January 21 at 7:13 AM
Lilly signs cancer drug deal worth up to $1.6 billionLilly signs cancer drug deal worth up to $1.6 billion
finance.yahoo.com - January 20 at 9:38 AM
Merus N.V. Announces Proposed Public Offering of Common Shares - Yahoo FinanceMerus N.V. Announces Proposed Public Offering of Common Shares - Yahoo Finance
finance.yahoo.com - January 19 at 11:38 PM
Form 8-K Merus NV For: Jan 18 - StreetInsider.comForm 8-K Merus NV For: Jan 18 - StreetInsider.com
streetinsider.com - January 19 at 6:37 PM
Form 424B5 Merus NV - StreetInsider.comForm 424B5 Merus NV - StreetInsider.com
streetinsider.com - January 19 at 6:37 PM
Merus down 3% after announcing equity offer - Seeking AlphaMerus down 3% after announcing equity offer - Seeking Alpha
seekingalpha.com - January 19 at 6:37 PM
Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today - BenzingaWhy Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today - Benzinga
benzinga.com - January 19 at 6:37 PM
Merus N.V. Announces Proposed Public Offering of Common Shares - GlobeNewswireMerus N.V. Announces Proposed Public Offering of Common Shares - GlobeNewswire
globenewswire.com - January 19 at 6:37 PM
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies - PRNewswireLilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies - PRNewswire
prnewswire.com - January 19 at 6:37 PM
Merus N.V. Announces Proposed Public Offering of Common SharesMerus N.V. Announces Proposed Public Offering of Common Shares
finance.yahoo.com - January 19 at 6:37 PM
Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial - GlobeNewswireMerus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial - GlobeNewswire
globenewswire.com - January 13 at 7:00 AM
Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical TrialMerus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial
finance.yahoo.com - January 13 at 1:56 AM
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium - GlobeNewswireMerus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium - GlobeNewswire
globenewswire.com - January 12 at 2:22 AM
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium - Yahoo FinanceMerus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium - Yahoo Finance
finance.yahoo.com - January 11 at 9:21 PM
Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers SymposiumMerus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
benzinga.com - January 11 at 5:33 PM
Merus (MRUS) Stock Up on FDAs Fast Track Tag for Zenocutuzumab - Yahoo FinanceMerus (MRUS) Stock Up on FDA's Fast Track Tag for Zenocutuzumab - Yahoo Finance
finance.yahoo.com - January 11 at 4:17 PM
Merus N.V.: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion CancersMerus N.V.: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers
finanznachrichten.de - January 9 at 10:12 PM
Health Care Sector Update for 01/08/2021: MRUS,DNLI,SRPT - NasdaqHealth Care Sector Update for 01/08/2021: MRUS,DNLI,SRPT - Nasdaq
nasdaq.com - January 8 at 3:50 PM
Mid-Afternoon Market Update: Gold Dips 3.5%; Merus Shares Surge - BenzingaMid-Afternoon Market Update: Gold Dips 3.5%; Merus Shares Surge - Benzinga
benzinga.com - January 8 at 3:50 PM
U.S. to introduce fraud checks for small business pandemic aid program -sources - NasdaqU.S. to introduce fraud checks for small business pandemic aid program -sources - Nasdaq
nasdaq.com - January 8 at 10:50 AM
Health Care Sector Update for 01/08/2021: BNTX, PFE, MRUS, SRPT, XLV, IBB - NasdaqHealth Care Sector Update for 01/08/2021: BNTX, PFE, MRUS, SRPT, XLV, IBB - Nasdaq
nasdaq.com - January 8 at 10:50 AM
After-Hours Stock Movers 01/07: (MRUS) (MICT) (WDFC) Higher; (SRPT) (SLDB) (BNGO) Lower (more...) - StreetInsider.comAfter-Hours Stock Movers 01/07: (MRUS) (MICT) (WDFC) Higher; (SRPT) (SLDB) (BNGO) Lower (more...) - StreetInsider.com
streetinsider.com - January 7 at 7:28 PM
Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers - GlobeNewswireMerus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers - GlobeNewswire
globenewswire.com - January 7 at 7:28 PM
Merus rises 4% on Incyte stake disclosure - Seeking AlphaMerus rises 4% on Incyte stake disclosure - Seeking Alpha
seekingalpha.com - December 29 at 7:34 AM
Merus NV SC 13D Dec. 28, 2020 4:08 PM - Seeking AlphaMerus NV SC 13D Dec. 28, 2020 4:08 PM - Seeking Alpha
seekingalpha.com - December 29 at 7:34 AM
Merus NV (MRUS) Reports Agreement with Sema4 to Support Merus Phase 1/2 Clinical Trial of Zenocutuzumab - StreetInsider.comMerus NV (MRUS) Reports Agreement with Sema4 to Support Merus' Phase 1/2 Clinical Trial of Zenocutuzumab - StreetInsider.com
streetinsider.com - December 18 at 7:26 AM
Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab - Yahoo FinanceMerus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab - Yahoo Finance
finance.yahoo.com - December 17 at 8:40 AM
Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of ZenocutuzumabMerus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab
finance.yahoo.com - December 17 at 8:40 AM
Is MRUS A Good Stock To Buy Now? - Yahoo FinanceIs MRUS A Good Stock To Buy Now? - Yahoo Finance
finance.yahoo.com - December 14 at 1:38 PM
Is MRUS A Good Stock To Buy Now?Is MRUS A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 1:38 PM
Tarus Therapeutics Strengthens its Board of Directors with Appointment of Paolo Pucci - Yahoo Finance UKTarus Therapeutics Strengthens its Board of Directors with Appointment of Paolo Pucci - Yahoo Finance UK
uk.finance.yahoo.com - December 2 at 7:22 AM
MPC Capitals subsidiary Cairn Real Estate completes EUR 120 million capital increase for Gateway Fund - Yahoo Finance UKMPC Capital's subsidiary Cairn Real Estate completes EUR 120 million capital increase for Gateway Fund - Yahoo Finance UK
uk.finance.yahoo.com - November 16 at 3:05 PM
Merus to Present at the Jefferies Virtual London Healthcare Conference - Yahoo FinanceMerus to Present at the Jefferies Virtual London Healthcare Conference - Yahoo Finance
finance.yahoo.com - November 16 at 9:55 AM
Merus to Present at the Jefferies Virtual London Healthcare ConferenceMerus to Present at the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 16 at 9:55 AM
Form SC 13G Merus NV Filed by: FEDERATED HERMES, INC. - StreetInsider.comForm SC 13G Merus NV Filed by: FEDERATED HERMES, INC. - StreetInsider.com
streetinsider.com - November 10 at 1:21 PM
Merus Announces Poster Presentations on MCLA-145 at Society for Immunotherapy of Cancer - GlobeNewswireMerus Announces Poster Presentations on MCLA-145 at Society for Immunotherapy of Cancer - GlobeNewswire
globenewswire.com - November 9 at 12:19 PM
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.